NextEvo Naturals is a premium supplement brand that launched a proprietary delivery technology and an evidence-backed line of cannabidiol (CBD) products. Its SmartSorb™ technology creates a water-dispersible emulsion that the company says delivers the equivalent of four times the CBD versus oil-based formulations and enables rapid absorption. NextEvo cites evidence-based scientific trials demonstrating SmartSorb’s superiority and plans to conduct additional trials this year. The company’s research team includes medical and scientific professionals with over 100 years of combined experience at organizations such as Johnson & Johnson and GlaxoSmithKline. Initial products include 10 mg and 15 mg THC-free high-absorption CBD capsules (the 15 mg is also available as a mint chewable) and a Triple Action Sleep capsule combining 5 mg CBD with immediate and controlled-release melatonin. All products are manufactured in an FDA-inspected, GMP-certified facility and are independently tested by an ISO/IEC-accredited third-party testing facility. NextEvo used proceeds from a $15 million investment round to support pre-launch development and commercialization of its initial product line.

Total raised

$15M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2022